{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:25:28Z","timestamp":1790144728704,"version":"4.0.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To describe the response to long-term topical dorzolamide treatment in patients with juvenile X-linked retinoschisis and cystic-like foveal lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective interventional case series that included 18 eyes of 10 patients with genetically confirmed juvenile X-linked retinoschisis examined at the Cleveland Clinic Cole Eye Institute, a tertiary referral center, between 2005 and 2021. Patients were treated with topical 2% dorzolamide two to three times daily in both eyes. Two eyes were excluded because of retinal detachment. Primary outcome measures were logarithm of minimum angle of resolution visual acuity and optical coherence tomography based central subfield thickness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mean follow-up was 8.38 years (SD, 3.41 years). The mean baseline and final central subfield thickness was 429.88 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m (SD, 143.36 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m) and 372.28 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m, respectively (SD, 147.13 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.10). The mean baseline and final logarithm of minimum angle of resolution visual acuity was 0.45 (SD, 0.17) and 0.34, respectively (SD, 0.22, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). None of the patients experienced any side effects from topical dorzolamide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The study data support previous reports of improved visual acuity in X-linked retinoschisis patients on topical dorzolamide treatment. This is the longest follow-up for a series of juvenile X-linked retinoschisis patients treated with a topical carbonic anhydrase inhibitor to date. A large, prospective, randomized clinical trial is needed to provide stronger evidence regarding the efficacy of topical carbonic anhydrase inhibitors in juvenile X-linked retinoschisis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003588","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T04:01:14Z","timestamp":1660881674000},"page":"2176-2183","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS"],"prefix":"10.1097","volume":"42","author":[{"given":"Melanie A.","family":"Schmitt","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6668-4041","authenticated-orcid":false,"given":"Kevin","family":"Wang","sequence":"additional","affiliation":[{"name":"The Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan J.","family":"DeBenedictis","sequence":"additional","affiliation":[{"name":"The Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias I.","family":"Traboulsi","sequence":"additional","affiliation":[{"name":"The Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/nar\/30.1.52","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"30","author":"Hamosh","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R3-20250607","first-page":"343","article-title":"Ueber das zusammenvorkommen von veranderungen der retina und choroidea","volume":"37","author":"Haas","year":"1898","journal-title":"Arch Augenheilkd"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00291666","article-title":"DNA linkage analysis of X-linked retinoschisis","volume":"78","author":"Dahl","year":"1988","journal-title":"Hum Genet"},{"key":"R5-20250607","first-page":"616","article-title":"Linkage relationship of X-linked juvenile retinoschisis with Xp22.1-p22.3 probes","volume":"47","author":"Sieving","year":"1990","journal-title":"Am J Hum Genet"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng1097-164","article-title":"Positional cloning of the gene associated with X-linked juvenile retinoschisis","volume":"17","author":"Sauer","year":"1997","journal-title":"Nat Genet"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2011.12.002","article-title":"X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms","volume":"31","author":"Molday","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ophtha.2021.11.019","article-title":"X-linked retinoschisis: deep phenotyping and genetic characterization","volume":"129","author":"Georgiou","year":"2022","journal-title":"Ophthalmology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bjo.79.7.697","article-title":"X linked retinoschisis","volume":"79","author":"George","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archopht.1968.03850040051014","article-title":"Histopathology of juvenile retinoschisis","volume":"79","author":"Yanoff","year":"1968","journal-title":"Arch Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1167\/iovs.14-13955","article-title":"Correlation between spectral-domain OCT findings and visual acuity in X-linked retinoschisis","volume":"55","author":"Yang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2014.05.028","article-title":"Optical coherence tomography retinal thickness and volume measurements in X-linked retinoschisis","volume":"158","author":"Andreoli","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.oret.2018.09.006","article-title":"Wide-field swept-source OCT and angiography in X-linked retinoschisis","volume":"3","author":"Han","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 gene therapy for x-linked retinoschisis: initial findings from a phase i\/iia trial by intravitreal delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol Ther"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.iae.0000237081.80600.51","article-title":"Use of dorzolamide for patients with X-linked retinoschisis","volume":"26","author":"Apushkin","year":"2006","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/S0004-27492008000200030","article-title":"Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report","volume":"71","author":"Bastos","year":"2008","journal-title":"Arq Bras Oftalmol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2008.07.041","article-title":"Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin","volume":"147","author":"Walia","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archophthalmol.2009.398","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IAE.0b013e3181e587f9","article-title":"The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis","volume":"31","author":"Thobani","year":"2011","journal-title":"Retina"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/eye.2011.91","article-title":"X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype","volume":"25","author":"Khandhadia","year":"2011","journal-title":"Eye (Lond)"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.oftal.2013.06.012","article-title":"A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis","volume":"89","author":"Rocha Cabrera","year":"2014","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/08820538.2012.667496","article-title":"X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature","volume":"28","author":"Ali","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/13816810.2013.779383","article-title":"Resolution of with the use of dorzolamide","volume":"35","author":"Collison","year":"2014","journal-title":"Ophthalmic Genet"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13256-016-0905-8","article-title":"Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report","volume":"10","author":"Sadaka","year":"2016","journal-title":"J Med Case Rep"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/IAE.0000000000001379","article-title":"Use of a carbonic anhydrase inhibitor in x-linked retinoschisis: effect on cystic-appearing macular lesions and visual acuity","volume":"37","author":"Andreuzzi","year":"2017","journal-title":"Retina"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajoc.2017.07.008","article-title":"Treatment of cystic cavities in X-linked juvenile retinoschisis: the first sequential cross-over treatment regimen with dorzolamide","volume":"8","author":"Coussa","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","article-title":"Proper method for calculating average visual acuity","volume":"13","author":"Holladay","year":"1997","journal-title":"J Refract Surg"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2013.10.025","article-title":"Acetazolamide in retinoschisis: a prospective study","volume":"121","author":"Gurbaxani","year":"2014","journal-title":"Ophthalmology"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/IAE.0b013e3181ff0d2d","article-title":"Effect of aging on macular features of X-linked retinoschisis assessed with optical coherence tomography","volume":"31","author":"Menke","year":"2011","journal-title":"Retina"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2021.09.021","article-title":"X-linked retinoschisis: novel clinical observations and genetic spectrum in 340 patients","volume":"129","author":"Hahn","year":"2022","journal-title":"Ophthalmology"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ophtha.2003.05.031","article-title":"Temporal variation in diabetic macular edema measured by optical coherence tomography","volume":"111","author":"Frank","year":"2004","journal-title":"Ophthalmology"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00417-008-1011-4","article-title":"Diurnal variation of macular oedema in CRVO: prospective study","volume":"247","author":"Gupta","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13816810.2018.1466340","article-title":"Diurnal variations of foveoschisis by optical coherence tomography in patients with RS1 X-linked juvenile retinoschisis","volume":"39","author":"Abalem","year":"2018","journal-title":"Ophthalmic Genet"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/01.iae.0000223711.64467.d8","article-title":"Intraschisis cavity fluid composition in congenital X-linked retinoschisis","volume":"26","author":"Joshi","year":"2006","journal-title":"Retina"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0039-6257(99)00111-3","article-title":"Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group","volume":"44","author":"Silver","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.eye.6701353","article-title":"Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects","volume":"18","author":"Stewart","year":"2004","journal-title":"Eye (Lond)"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:03:22Z","timestamp":1749319402000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003588","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}